Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Moodys
US Department of Justice
Fish and Richardson
Chubb
US Army
Deloitte
Healthtrust
Cipla

Generated: June 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075636

« Back to Dashboard

NDA 075636 describes LOVASTATIN, which is a drug marketed by Actavis Elizabeth, Apotex Inc, Carlsbad, Lupin, Mylan, Sandoz, Sun Pharm Industries, and Teva, and is included in ten NDAs. It is available from forty-two suppliers. Additional details are available on the LOVASTATIN profile page.

The generic ingredient in LOVASTATIN is lovastatin. There are thirty-three drug master file entries for this compound. Forty-three suppliers are listed for this compound. Additional details are available on the lovastatin profile page.
Summary for 075636
Tradename:LOVASTATIN
Applicant:Sandoz
Ingredient:lovastatin
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 075636
Medical Subject Heading (MeSH) Categories for 075636
Suppliers and Packaging for NDA: 075636
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LOVASTATIN lovastatin TABLET;ORAL 075636 ANDA KAISER FOUNDATION HOSPITALS 0179-1433 N 0179-1433-01
LOVASTATIN lovastatin TABLET;ORAL 075636 ANDA KAISER FOUNDATION HOSPITALS 0179-1434 N 0179-1434-30

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Dec 17, 2001TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Dec 17, 2001TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength40MG
Approval Date:Dec 17, 2001TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Mallinckrodt
Federal Trade Commission
UBS
Julphar
Accenture
AstraZeneca
Dow
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.